Xr Securities LLC Amgen Inc Put Options Transaction History

Xr Securities LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 05, 2024	SELL	$262.75 - $319.31 $2.81 Million - $3.42 Million	-10,700 Reduced 75.35%	3,500 $1.09 Million
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $1.64 Million - $1.98 Million	6,100 Added 75.31%	14,200 $4.04 Million
Q4 2023 Feb 02, 2024	BUY	$255.7 - $288.46 $997,230 - $1.12 Million	3,900 Added 92.86%	8,100 $2.33 Million
Q3 2023 Oct 26, 2023	BUY	$218.65 - $271.46 $327,975 - $407,189	1,500 Added 55.56%	4,200 $1.13 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $321,405 - $380,055	1,500 Added 125.0%	2,700 $599,000
Q1 2023 May 02, 2023	SELL	$225.79 - $275.2 $1.35 Million - $1.65 Million	-6,000 Reduced 83.33%	1,200 $290,000
Q4 2022 Jan 23, 2023	BUY	$229.03 - $291.01 $1.65 Million - $2.1 Million	7,200 New	7,200 $0
Q3 2019 Oct 03, 2019	SELL	$174.11 - $208.62 $2.68 Million - $3.21 Million	-15,400 Closed	0 $0
Q2 2019 Jul 10, 2019	BUY	$166.7 - $195.41 $850,170 - $996,591	5,100 Added 49.51%	15,400 $52,000
Q1 2019 Apr 08, 2019	BUY	$180.87 - $203.88 $1.86 Million - $2.1 Million	10,300 New	10,300 $83,000

3,080

404M

7.56M

7.16M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $147B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.